Health Press Release – Newsletter for March 9, 2011

Jubilant Sets up Global Scale Capacities for Symtet – Developed Through Inhouse R&D

SYMTET is the Key Ingredient for Chlorpyrifos ( World's Largest Insecticide)

NOIDA, India, March 8, 2011 – Jubilant Life Sciences Ltd (formerly Jubilant Organosys Ltd)
an integrated Pharma and Life Sciences company and the largest Custom
Research & Manufacturing player out of India, announced today that it is
setting up a manufacturing plant for "2,3,5,6-Tetra Chloro Pyridine" (also
commercially …. Original article on Gaea Times at  : Jubilant Sets up Global Scale Capacities for Symtet – Developed Through Inhouse R&D.

Chronic Kidney Disease and Cardiovascular Risk

Policy options for tackling Europe's major health burdens
STRASBOURG, France, March 8, 2011 – The European Kidney Health Alliance (EKHA) and World Kidney Day (WKD)
organisations today call for urgent European Union (EU) action to curb the
increasing burden of chronic kidney disease (CKD) and associated diseases.

The Members of European Parliament (MEP) Group …. Source  : Gaea News Network.

Leading Medical Technology Company CNSystems is Austria’s Representative at the International Symposium on Intensive Care and Emergency Medicine

GRAZ, Austria, March 8, 2011 – This is a great success for CNSystems. The well-established
Austrian high tech company will be presenting its CNAP (Continuous
Non-invasive Arterial Pressure) blood pressure measuring device, as well as,
for the first time, evaluation data at the International Symposium on
Intensive Care and Emergency Medicine in Brussels.

Over the … Read : Leading Medical Technology Company CNSystems is Austria's Representative at the International Symposium on Intensive Care and Emergency Medicine.

ProFibrix Initiates Phase II With Lead Hemostasis Product Fibrocaps(TM) in US and Europe

LEIDEN, The Netherlands and SEATTLE, March 8, 2011 – ProFibrix B.V., a leader in the development of innovative
products for hemostasis, today announced that it has initiated a prospective,
multi-center Phase II study with its lead product Fibrocaps at up to 20
sites, including major U.S. and Dutch academic medical centers.

Jaap Koopman, CEO … Read the original article on Gaea Times at : ProFibrix Initiates Phase II With Lead Hemostasis Product Fibrocaps(TM) in US and Europe.

Bupa International Launches Free Online Health Assessment

LONDON, March 8, 2011 – Bupa International has announced the launch of its free online health
assessment.

The assessments are part of the Bupa International's new health section
on its website, which has more than 50 factsheets and a series of health
theme pages which include articles and videos explaining medical issues.
… Read this article on Gaea Times at : Bupa International Launches Free Online Health Assessment.

QPS Expands Clinical Trial Services with Acquisition of Qualitix

Broadens later stage capabilities and Increases Asian presence
NEWARK, Delaware and TAIPEI, Taiwan, March 8, 2011 – QPS, LLC, a leading full-service GLP/GCP-compliant contract research
organization providing testing services to support preclinical and clinical
research and development, announced the acquisition of a majority interest of
Qualitix Clinical Research. Qualitix, a spin-off of the biotechnology company
Genovate, Inc, is a … Read more >>.

Fenwal, Golden Meditech Complete Definitive Agreement to Form Joint Venture in China

New company to focus on products and technologies for blood collection, storage and transfusion

LAKE ZURICH, Illinois and HONG KONG, March 8, 2011 – Fenwal Inc. of Lake Zurich, Illinois, and Golden Meditech Holdings
Limited (stock code: 801.HK; 910801.TW) of Hong Kong announced today they
have entered into a definitive agreement to form a joint venture in …. Original article on Gaea Times at  : Fenwal, Golden Meditech Complete Definitive Agreement to Form Joint Venture in China.

UBM Announces Content for 10th Annual Japanese Pharma & Bio Events

AMSTERDAM, March 8, 2011 – Leading events organiser UBM Live (www.ubmlive.com) and its sister
company, UBM Japan Co. Ltd. (www.ubmjapan.com/corp/en/index.html),
today announced details of the anticipated content and new developments
taking place at the tenth anniversary of CPhI Japan, a leading International
pharmaceutical event, being held from 18-20 April, 2011 at the Big Sight
Exhibition Center in Tokyo. The …. Source  : UBM Announces Content for 10th Annual Japanese Pharma & Bio Events.